International Conference on Clinical Oncology and Pharmacology on March 02-04, 2023 in Zurich, Switzerland

Dear Colleagues,

On behalf of the Organizing Committee, we are honored to welcomes you to join and participate in the 4th International Conference on Clinical Oncologyand Pharmacology on March 02-04,2023 at Zurich, Switzerland

Clinical oncology is a massive platform for the distribution of knowledge, networking, innovations, unique concepts, and for collaboration. Young researchers and examiners deserve the best future and better chances in the related field and we trust that you can make it happen as well as successful.

Let’s join hands for the future of this world, for the next generation of mankind, for the potential and cooperative efforts to change what is within our reach and means. Our cooperative efforts have the power to change destiny. So friends, let’s live up to their opportunities and play a part in this Event. And gain more information and knowledge related to clinical oncology and pharmacology.

A designation of experts and specialists from all over the world is predicted to attend this conference. We are sure that this will provide excellent chances for young researchers, academicians, industry experts to share the latest views, values, practices, and experiences in this clinical oncology field.

We are looking forward to seeing your presence at our conference

Best Regards,
Organizing Committee
Clinical Oncology 2023

Session 1: Carcinoma

It is the most common type of cancer. It starts in the epithelial tissue of the skin, or in the tissue that lines internal organs, such as the kidneys or liver. Carcinomas may spread to other parts of the body or be limited to the primary location. They are believed to be the result of a combination of factors, including genetic factors, Carcinogens, asbestos, consumption of alcohol, tobacco smoke, radiation, or industrial chemicals. Certain viruses like the human papillomavirus, and hepatitis.

  Squamous Cell Carcinoma

  Renal Cell Carcinoma

  Rectal Cell Carcinoma


  Basal Cell Carcinoma

Session2: Sarcoma

Sarcoma is a type of cancer that starts in soft tissues or in the bones of the body, including fat, cartilage, muscle, blood vessels, fibrous tissue, or supportive or connective tissue. Different types of sarcoma are based on where the tumour forms. DNA changes in soft tissue sarcoma are common. But they're usually developed during life rather than having been inherited earlier in birth. Acquired mutations may result from the cancer-causing cells or heavy exposure to radiation. In most sarcomas, they happen for no actual reason. The total 5yr survival rate for sarcoma is 65%. About 60% of sarcomas are found as localized sarcoma. The 5-year survival rate for people with localized sarcoma is 81%. About 19% of sarcomas are found in a locally unconventional stage.


  Fibro Sarcoma

  Chondro Sarcoma

  Ewings - Sarcoma

Session 3: Melanoma

Melanoma, which means black tumour, is the supreme risky type of skin cancer it grows rapidly and has the capability to spread all over the body. Melanoma is the type of skin tumour that changes when melanocytes (the cells that give the skin its brown or tan colour) begin to mature out of control. For example, (UV) ultraviolet rays are undoubtedly a main cause of melanoma. UV rays can harm the DNA in skin cells. Sometimes these genes do no lengthier work properly, the affected cells may become cancer tumours. Variations in colour, shape and size or feel of a mole are often the first noticing signs of melanoma. These variations can occur in an existing mole, or melanoma may look like a new or unusual-looking mole. The "ABCDE" rule is helpful in memorizing the warning signs of melanoma.





Session4: Lymphoma

Lymphoma is a tumour that starts in infection-fighting cells of the immune system known as lymphocytes. These cells are in the lymph nodes, thymus, bone marrow, spleen and other parts of the body. When you have lymphoma, lymphocytes alter and mature out of control. Lymphoma is a rare, slow-growing type of lymphoma. It is found mostly in the bone marrow, spleen and lymph nodes. Persons of this type are usually alive many years with the disease, but it's typically not curable.


  Non –Hodgkin

Session 5: Leukaemia

The disease is characterized by the uncontrolled maturity of blood cells, usually (WBC) White blood cells in the bone marrow. White blood cells are the major component of the body’s immune response. Leukaemia cells are gathered out and replace the normal blood and marrow cells.

Autolymphocytic leukaemia

Auto myeloid leukaemia

Chronic lymphocytic leukaemia

Chronic myeloid leukaemia

Many different tests exist to detect and measure almost any type of chemical component in blood or urine. Components may include blood glucose, electrolytes, enzymes, hormones, lipids (fats), other metabolic substances, and proteins. an unusual expansion of skin cells. It usually develops in areas that are exposed to the sun, but it can also form in areas that don’t generally get sun exposure. The two main types of skin tumours are defined by the cells-

 Keratinocyte carcinoma


Session6: Lung Cancer

Lung cancer starts in the lungs and may spread to lymph nodes or other parts of the body, such as the brain. Cancer from other body parts also may spread to the lungs. When cancer cells spread from one another, they are called metastases. Lung cancer cells commonly are grouped into two main categories known small cell and non-small cell (including squamous cell and adenocarcinoma). These type of lung cancer develops differently and are treated differently. Non-small cell lung cancer is more common than small cell lung tumours.

Types of Treatment in lung cancer. Lung cancer is treated in numerous ways, depending on the kind of lung cancer and how distant it has spread. Persons with non-small cell lung tumours can be treated which chemotherapy, surgery, radiation therapy, targeted therapy, or a combination of any of these treatments. People with small cell lung cancer are normally treated with radiation therapy and chemotherapy.



 Radiation therapy

 Session 7: Breast Cancer

 Breast cancer, The type of breast tumour depends on which cells in the breast changes into cancer

  Invasive ductal carcinoma

  Invasive lobular carcinoma

cancer is an infection in which cells in the breast develop out of control. There are different types of breast,

Invasive Ductal Carcinoma- The tumour cells begins in the ducts and then develop outside of the ducts in to other parts of the breast tissue. Invasive cancer cells are also spreader, or metastasized, to Invasive Lobular Carcinoma

Invasive Lobular Carcinoma- The Cancer cells started in the lobules and then spread from lobules to the breast tissues that are close by. These invasive cancer cells can also spread to various parts of the body.

Session 8: Bladder Cancer

The other parts of the body. make up the urinary bladder begins to develop or grow out of control. As more cancer cells develop, they can form a cancer cell and, with time, that spreads to the other parts of the body. The bladder is a hollow organ in the inferior pelvis. It Contains flexible, muscular walls that stretch to hold urine and squeeze to send it out of the body. The bladder's main purpose is the collection and storing of urine. Urine is the liquid waste by the 2 kidneys and then carry out to the bladder with 2 tubes called ureters. When you urinate, the muscles in the bladder will contract, and urine is forced out of the bladder with a tube or pipe known as the urethra.

  Urothelial carcinoma

  Squamous cell carcinoma


  Small cell carcinoma

Other Types Of Bladder Cancer:

The Other types of cancer begin in the bladder, but these all are much less common than urothelial cancer. Squamous cell carcinoma In the US, only about 1% to 2% of bladder cancers are squamous cell carcinomas. Seen with a microscope, the cells look mostly like the flat cells that are found on the surface of the skin. Nearly all the squamous cell carcinomas are the bladders are invasive.

 Session9: Liver Cancer

 Liver cancer strikes chemicals. The liver participates in many other essential functions, such as removing poisons from twice as many men as women, at the average age of 67. Because the liver is made up of several different types of cells, numerous types of tumours can form there. Some of those are benign (noncancerous), and some are cancerous and can spread to the other parts of the body (metastasize). These tumour cells have different reasons and are treated differently. The most common benign tumours of the liver are-



  Hepatic adenoma



 Session10: Oesophageal Cancer

Oesophageal cancer is cancer that happens in the oesophagus — a lengthy, hollow tube that runs from the throat to the stomach within the body. The oesophagus helps to man-oeuvre the food from the back to the throat to the stomach for the digestion process. oesophageal cancer is the sixth commonest reason for the deaths of cancer worldwide. Incidence rates differ within different geographic places. In some regions, greater rates of oesophageal cancer are also recognized to be the usage of tobacco and alcohol or particular nutritional habits .oesophageal cancers are generally started within the cells within the oesophagus .oesophageal cancer occurs anyplace along the oesophagus. More men get oesophageal cancers than women.


 Squamous cell



 Small cell carcinoma

Session11: Ovarian Cancer

It is the most common reason for cancer death from gynecologic cancer cells in the United States. Malignant ovarian lesions contain primary lesions arising from usual structures within the ovary and secondary lesions from the cancers arising from a different place in the body. Primary lesions include epithelial ovarian carcinoma(70% of all are ovarian malignancies). Current researches suggest that the majority of those are originated from Fallopian tubes.

  Epithelial ovarian tumour

  Benign epithelial tumour

  Borderline epithelial tumour

  Malignant epithelial tumour

Session12: Mesothelioma Cancer

It is cancer that is caused by asbestos. It occurs most commonly inlining of the abdomen or the lungs. The average life span for this mesothelioma cancer is 18-31months diagnosis, but the diagnosis may recover with the treatment. Asbestos is only the exact cause of mesothelioma. When these asbestos fibres are in-digested or inhaled they may become inserted into the lining of the heart, lungs or abdomen. Over time the fibres can cause carrying and inflammation. This irritation can lead to the development of mesothelioma tumours based on the location. The major common tumours are three and are made up of different cell types.




Session13: Diagnosing Of Cancer

Clinical chemistry uses chemical procedures to measure the level of chemical components in the body tissues and fluids. The most used specimens in clinical chemistry are urine and blood. There are so many tests that are there to detect and measure almost any kind of chemical factor in blood or urine. Components may include enzymes, blood glucose, lipids, electrolytes, hormones, other metabolic substances, and proteins. There are some of the common laboratory tests:


  Complete blood count (CBC)


Types of Diagnostic Imaging: Transmission imaging -CT scan, X-rays and fluoroscopy are the radiological examinations by transmission. In this, a beam of energy photon is produced and passed through the body for examination. The beam passes very rapidly or fastly through a low dense type of tissues like fat, and blood.

 Session14: Cancer Chemotherapy And Pharmacology

Cancer Chemotherapy and Pharmacology address a wide range of pharmacology and oncology concerns on the together experimental and clinical levels. The main focus of this rapid publication medium is on the new anti-cancer agents, and their experimental showing, preclinical toxicology and pharmacology, solo and or combined drug administration modalities, and phase 1, 2 and 3 clinical trials. Clinical toxicology, pharmacodynamics, pharmacokinetics, drug interactions, and signs for chemotherapy in tumour treatment strategy. Cancer Chemotherapy and Pharmacology is an important analysis for oncologists and pharmacologists. It offers results in the linked fields like pharmacokinetics pharmacodynamics, clinical toxicology, signs for chemotherapy and drug interactions are the tumour treatment strategy. It addresses an extensive range of oncologic and pharmacologic worries.

  Phase-1 clinical trials

  Phase -2 clinical trials

  Phase -3 clinical trials

Session 15: cancer vaccines and immunotherapy

Chemotherapy is also known as chemo which is the treatment given with drugs that block or stop the growth of the cell .mostly for cancer cells. After the discovery and use of the X-rays for treatment and diagnosing of the tumour, they have been standoff for investigation of newer treatments which are used in cancer care. This significant change in the treatment of tumour cells took place around the ’40s of the 2oth century, with the sudden and accidental discovery of the first DNA alkylating agent.

  Therapeutic vaccines



Session16: Cancer Metabolism

It is a method or process in which cancer cells make the energy they want to develop and spread. It is a target for investigators working to end or slow down cancers. Metabolism is how the cells in the body use carbohydrates, proteins and fats from food to get the energy they want to mature and stay healthy. Cancer cells do in a different way. Related healthy cells, can use lots of glucose and they generate low energy while creating what they want to multiply and then spread.

New Approaches-

Researchers are working to walk up with new ideas to hinder cancer metabolism. This type of work is in earlier stages, mostly in laboratory studies and tests on animals. And in the case of people, it is not yet ready. potential targets include-


 Amino acids

 Cancers Messaging Systems.

Session17: Viral Oncology

Oncoviralinfections are common, but these infections rarely result in cancer. One or more extra insults, such as chronic environmental mutagens, immunosuppression, and inflammation are essential for cancer growth. Additionally, viruses are only an unconditional requirement for oncogenesis in Kaposi sarcoma and in cervical cancer. Onco-viruses are divided as direct or indirect carcinogens, even though some overlay exists between the distinctions. Direct carcinogenic viruses have viral oncogenes that directly donate to neoplastic cellular transformation, whereas UN-planned carcinogens cause chronic inflammation which can lead to oncogenic transformation. Oncogenic DNA viruses like hepatitis B virus (HBV), human papillomavirus (HPV), EVB, human herpesvirus-8 (HHV-8), and Merkel cell polyomavirus (MCPyV). Oncogenic RNA viruses contain hepatitis C virus (HCV) and human T-cell lymphotropic virus-1 (HTLV-1).

  EBV creates latency in resting memory B-cells

  EBV oncogenic proteins

  EBV and T cell lymph proliferative disorders

  EBV and epithelial malignancies

  EBV and B-cell lymph proliferative disorders

Session18: Precision Cancer Medicine

There is no repetitive cancer. Each and every person’s cancer is altered with different stages, individually matchless genes and molecules driving the person's particular disease precision medicine are also termed personalized medicine can have limited or fewer side effects than the other form of cancer treatment. Precision cancer medicine may affect less healthy cells and be more intricate in cancer.

Pharmacogenomics: researchers can study how the genes affect your response to the drugs .which is known as pharmacogenomics showing your genes affect drugs in the body and makes a variation. It regulates how well a drug is working for us and how safe it was.

The future of personalized cancer medicine:

Personalized cancer medicine will make cancer treatment more active and effective, with fewer side effects. But they contain some challenges still that include:

Personalized treatment is not available for all the types and sub-types of the cancer

Some of the personalized treatments like targeted treatment were expensive in nature.

Examples of personalized cancer medicine: This involves targeted therapy- the targeted therapy targets the particular genes and proteins that allow definite cancer to develop and live. researchers find new targets for more cancer each year. After that, they create and test new drugs for those targets cancers with targeted treatment for some people like bladder cancer, brain cancer, breast cancer etc

Types of personalized cancer medicine:

  1.  Melanoma
  2.  Oesophageal cancer
  3.  Thyroid cancer
  4.  Lung cancer
  5.  Breast cancer

Session19: oncology specialists

Different type of cancers affects different parts of the body .for example liver, lungs, breast or any other part of the body .or other organs behave in a different manner. This commands the use of various specialists oncologists and does away with a one size fits all method. Cancer care is a multidisciplinary method and contains a team of professionals.

Sub-specialists of oncologists like radiation oncology, surgical oncology, gynaecological oncology, paediatric oncology other sub-specialists involve neuron- oncology, ha-mate-oncology, uro- oncology

Multi-disciplinary team: A medical oncologist was the team coordinator who manages diagnosis, treatment planning, and management of cancer-related problems and followed by the radiation oncologist, surgical oncologists, pathologists specialized doctors, cosmetic surgeons, and assistants for physicians.

  •  Radiation oncology
  •  Gynecology
  •  Pediatric oncology
  •  Neuro-oncology


Name: Allied Conferences
Address: berkshire

It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims
Description Price Date
Speaker Registeration USD 899.00 After September 22, 2022
Delegates USD 699.00 After September 22, 2022
Young Research Forum USD 599.00 After September 23, 2022
Video Presentation USD 299.00 After September 22, 2022
Poster Presentation USD 150.00 After September 23, 2022
E-poster Presentation USD 199.00 After September 15, 2022